Have Patent License, Will Sue: Medtronic, Boston Sci Face Off In Supreme Court
This article was originally published in The Gray Sheet
Executive Summary
Medtronic appeared to have the edge over Boston Scientific in Nov. 5 oral arguments over which side needs to prove its case when a patent licensee sues its licensor to get out of paying product royalties. The Supreme Court ruling has implications for which side has more leverage in licensing agreements, which are common in the device industry.